While much progress has been made in the last two decades in the treatment and the
management of inflammatory bowel diseases (IBD)—both ulcerative colitis (UC) and …

Macrophages as innate immune cells and fast responders to antigens play a central role in
protecting the body from the luminal content at a huge interface. Chronic inflammation in …

Inflammatory bowel disease (IBD) is an abnormal inflammatory response within the gut to a
trigger that has yet to be identified. The family history in many patients, especially those with …

Inflammatory bowel disease (IBD), comprising Crohn's disease (CD) and ulcerative colitis
(UC), is a heterogeneous state of chronic intestinal inflammation with no exact known cause …

Background: Long-term management of inflammatory bowel diseases (IBD) is challenging
and the identification of reliable predictors for treatment outcomes is an unmet need …

Inflammatory bowel disease (IBD), encompassing Crohn's disease (CD) and ulcerative
colitis (UC), is a chronic inflammatory disorder caused by dysregulated immune responses …

The innate immune system not only serves as a first line of defense against infections with
pathogenic microorganisms but also plays an important role in the balanced interplay with …

The chronic inflammatory bowel diseases (IBD), Crohn's disease and ulcerative colitis, are
recognized as important causes of gastrointestinal disease in children and adults. Insight …

The exact pathophysiology of inflammatory bowel disease (IBD) is still unknown. However,
over the years important insights allowed the development of novel therapeutic approaches …